Compile Data Set for Download or QSAR
Found 90 with Last Name = 'rojas de la parra' and Initial = 'v'
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207849(US9266832, Cpd006)copy SMILEScopy InChI
Affinity DataEC50:  256nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207852(US9266832, Cpd009)copy SMILEScopy InChI
Affinity DataEC50:  240nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207853(US9266832, Cpd010)copy SMILEScopy InChI
Affinity DataEC50:  78nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207854(US9266832, Cpd011)copy SMILEScopy InChI
Affinity DataEC50:  173nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207855(US9266832, Cpd012)copy SMILEScopy InChI
Affinity DataEC50:  486nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207858(US9266832, Cpd015)copy SMILEScopy InChI
Affinity DataEC50:  154nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207861(US9266832, Cpd018)copy SMILEScopy InChI
Affinity DataEC50:  168nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207862(US9266832, Cpd019)copy SMILEScopy InChI
Affinity DataEC50:  103nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207865(US9266832, Cpd022)copy SMILEScopy InChI
Affinity DataEC50:  159nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207866(US9266832, Cpd023)copy SMILEScopy InChI
Affinity DataEC50:  94nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207867(US9266832, Cpd024)copy SMILEScopy InChI
Affinity DataEC50:  724nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207869(US9266832, Cpd026)copy SMILEScopy InChI
Affinity DataEC50:  83nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207871(US9266832, Cpd028)copy SMILEScopy InChI
Affinity DataEC50:  370nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207872(US9266832, Cpd029)copy SMILEScopy InChI
Affinity DataEC50:  84nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207873(US9266832, Cpd030)copy SMILEScopy InChI
Affinity DataEC50:  96nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207874(US9266832, Cpd031)copy SMILEScopy InChI
Affinity DataEC50:  16nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207875(US9266832, Cpd032)copy SMILEScopy InChI
Affinity DataEC50:  14nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207876(US9266832, Cpd033)copy SMILEScopy InChI
Affinity DataEC50:  31nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207877(US9266832, Cpd034)copy SMILEScopy InChI
Affinity DataEC50:  62nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207878(US9266832, Cpd035)copy SMILEScopy InChI
Affinity DataEC50:  60nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207879(US9266832, Cpd036)copy SMILEScopy InChI
Affinity DataEC50:  40nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207880(US9266832, Cpd037)copy SMILEScopy InChI
Affinity DataEC50:  32nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207881(US9266832, Cpd038)copy SMILEScopy InChI
Affinity DataEC50:  31nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207882(US9266832, Cpd039)copy SMILEScopy InChI
Affinity DataEC50:  22nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207883(US9266832, Cpd040)copy SMILEScopy InChI
Affinity DataEC50:  103nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207884(US9266832, Cpd041)copy SMILEScopy InChI
Affinity DataEC50:  80nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207885(US9266832, Cpd042)copy SMILEScopy InChI
Affinity DataEC50:  31nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207887(US9266832, Cpd044)copy SMILEScopy InChI
Affinity DataEC50:  55nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207888(US9266832, Cpd045)copy SMILEScopy InChI
Affinity DataEC50:  22nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207889(US9266832, Cpd046)copy SMILEScopy InChI
Affinity DataEC50:  7nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207890(US9266832, Cpd047)copy SMILEScopy InChI
Affinity DataEC50:  65nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207891(US9266832, Cpd048 | US9266832, Cpd084)copy SMILEScopy InChI
Affinity DataEC50:  13nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207892(US9266832, Cpd049)copy SMILEScopy InChI
Affinity DataEC50:  31nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207893(US9266832, Cpd050)copy SMILEScopy InChI
Affinity DataEC50:  50nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207895(US9266832, Cpd052)copy SMILEScopy InChI
Affinity DataEC50:  20nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207896(US9266832, Cpd053)copy SMILEScopy InChI
Affinity DataEC50:  17nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207897(US9266832, Cpd054)copy SMILEScopy InChI
Affinity DataEC50:  42nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207898(US9266832, Cpd055)copy SMILEScopy InChI
Affinity DataEC50:  36nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207899(US9266832, Cpd056)copy SMILEScopy InChI
Affinity DataEC50:  70nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207900(US9266832, Cpd057)copy SMILEScopy InChI
Affinity DataEC50:  147nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207901(US9266832, Cpd058)copy SMILEScopy InChI
Affinity DataEC50:  125nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207902(US9266832, Cpd059)copy SMILEScopy InChI
Affinity DataEC50:  68nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207903(US9266832, Cpd060)copy SMILEScopy InChI
Affinity DataEC50:  116nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207904(US9266832, Cpd061)copy SMILEScopy InChI
Affinity DataEC50:  86nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207905(US9266832, Cpd062)copy SMILEScopy InChI
Affinity DataEC50:  398nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207907(US9266832, Cpd064)copy SMILEScopy InChI
Affinity DataEC50:  122nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207908(US9266832, Cpd065)copy SMILEScopy InChI
Affinity DataEC50:  174nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207909(US9266832, Cpd066)copy SMILEScopy InChI
Affinity DataEC50:  386nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207910(US9266832, Cpd067)copy SMILEScopy InChI
Affinity DataEC50:  111nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND

US Patent
LigandPNGBDBM207911(US9266832, Cpd068)copy SMILEScopy InChI
Affinity DataEC50:  148nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2319TP6US Patent
Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: